InvestorsHub Logo
Followers 103
Posts 13609
Boards Moderated 1
Alias Born 01/23/2004

Re: dcmski post# 104220

Thursday, 12/21/2023 9:51:03 PM

Thursday, December 21, 2023 9:51:03 PM

Post# of 104535
Short version

Courtesy of Jaythree QMC hired Lobbyist
"The third quarterly reports from Podesta Lobbying Group is out. Again, good news as far as I am concerned. Still Lobbying, yeah !!"

https://projects.propublica.org/represent/lob.../301036564


32:11 mark


QMC Health Inc. Obtains Exclusive Rights to Novel Long COVID Biomarkers in Development of High Sensitivity Long COVID Rapid Test
November 01, 2022
https://www.globenewswire.com/en/news-release/2022/11/01/2545381/0/en/QMC-Health-Inc-Obtains-Exclusive-Rights-to-Novel-Long-COVID-Biomarkers-in-Development-of-High-Sensitivity-Long-COVID-Rapid-Test.html

and supposedly this e-mail from the company back sometime in March

Hi and thank you for your inquiry,
The company and its staff are intensely focused on optimizing its rapid diagnostic test platform technologies. We have organized clinical trials for our covid, flu, RSV multi-test and anticipate these should begin early May 2023 with the goal of having this test available for the next flu season. Our pre-submission has already been submitted to the FDA and we believe this test will be processed under the EUA.
We are continuing to develop our long covid rapid test striving to have it ready for clinical trials before the end of 2023.

Our CFO and his staff re continuing to work to position the company to submit an S1 before the end of this year. In the meantime, our limited financial resources will continue to be largely focused on the commercialization of our products until such a time sustainable revenues are achieved.

Thank you again for your inquiry and your patience as we work to bring our disruptive technologies to market.

Amber



Other than that rather quiet the past year.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.